ANNA WENDEL: Open Payments
NPI 1437703675 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 31 payments from 10 companies in 2025. Trend: 2023 $1,848 · 2024 $280 · 2025 $744
Food & beverage: $638Education: $106
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $166 |
| Novartis Pharmaceuticals Corporation | 5 | $159 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $131 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Optinose US, Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| ALK-Abello, Inc | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $20 |
| Organon LLC | 1 | $18 |
Products named: DUPIXENT, NEFFY, Xhance, TRELEGY ELLIPTA, AIRSUPRA, TEZSPIRE, Grastek, XOLAIR.
Industry payments across TX — which companies pay providers there.
